On February 2, 2024, Zhejiang Chemsyn Pharm Co.,Ltd (“ZCPC”, stock code 870656) was successfully listed on the Beijing Stock Exchange. T&C Law Firm acted as the issuer’s lawyer.

ZCPC mainly engages in the research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates. Since its establishment in 2007, the company has gradually grown into a production enterprise of veterinary drug raw materials centered on anti-microbials and anti-parasites, and pharmaceutical raw materials centered on anti-pyretic, analgesic and antibacterial drugs, forming the advantage of simultaneous development of veterinary drug raw materials and pharmaceutical raw materials. It is one of the enterprises with the longest industrial chain, the most complete varieties and the most competitive sulfonamide raw materials and intermediates in the industry. Through this public listing, ZCPC issued 20 million shares (excluding the over-allotment option), with an issue price of 19.90 RMB per share, and the total amount of funds raised is 398 million RMB.

As the issuer's lawyer of ZCPC in this listing, T&C Law Firm has provided a full-process, high-quality and multi-dimensional legal service for T&C Law Firm, which wins T&C Law Firm high recognition from the client and all parties.